Hydralazine | Approved | REN | 5972 |
increased | Hydralazine results in increased expression of REN protein | 1q32.1 | |
Furosemide | Approved Vet Approved | REN | 5972 |
increased | Furosemide results in increased expression of REN protein | 1q32.1 | |
Furosemide | Approved Vet Approved | REN | 5972 |
increased | Furosemide results in increased expression of REN protein | 1q32.1 | |
Ritodrine | Approved Investigational | INS | 3630 |
increased | Ritodrine results in increased expression of INS protein | 11p15.5 | |
Ritodrine | Approved Investigational | INS | 3630 |
increased | Ritodrine results in increased expression of INS protein | 11p15.5 | |
Epinephrine | Approved Vet Approved | INS | 3630 |
decreased | Epinephrine results in decreased expression of INS protein | 11p15.5 | |
Epinephrine | Approved Vet Approved | INS | 3630 |
decreased | Epinephrine results in decreased expression of INS protein | 11p15.5 | |
Chlorpromazine | Approved Investigational Vet Approved | PRL | 5617 |
increased | Chlorpromazine results in increased expression of PRL protein | 6p22.3 | |
Chlorpromazine | Approved Investigational Vet Approved | PRL | 5617 |
increased | Chlorpromazine results in increased expression of PRL protein | 6p22.3 | |
Spironolactone | Approved | AGT | 183 |
increased | Spironolactone results in increased expression of AGT protein modified form | 1q42.2 | |
Spironolactone | Approved | AGT | 183 |
increased | Spironolactone results in increased expression of AGT protein modified form | 1q42.2 | |
Heparin | Approved Investigational | SERPINC1 | 462 |
decreased | Heparin results in decreased expression of SERPINC1 protein | 1q25.1 | |
Hydrocortisone | Approved Vet Approved | INS | 3630 |
increased | Hydrocortisone results in increased expression of INS protein | 11p15.5 | |
Hydrocortisone | Approved Vet Approved | INS | 3630 |
increased | Hydrocortisone results in increased expression of INS protein | 11p15.5 | |
Octreotide | Approved Investigational | INS | 3630 |
decreased | Octreotide results in decreased expression of INS protein | 11p15.5 | |
Methotrexate | Approved | COL3A1 | 1281 |
increased | Methotrexate results in increased expression of COL3A1 protein | 2q32.2 | |
Beclomethasone dipropionate | Approved Investigational | BGLAP | 632 |
decreased | Beclomethasone results in decreased expression of BGLAP protein | 1q22 | |
Beclomethasone dipropionate | Approved Investigational | BGLAP | 632 |
decreased | Beclomethasone results in decreased expression of BGLAP protein | 1q22 | |
Lansoprazole | Approved Investigational | GAST | 2520 |
increased | Lansoprazole results in increased expression of GAST protein | 17q21.2 | |
Lansoprazole | Approved Investigational | GAST | 2520 |
increased | Lansoprazole results in increased expression of GAST protein | 17q21.2 | |
Bezafibrate | Approved Investigational | APOA2 | 336 |
increased | Bezafibrate results in increased expression of APOA2 protein | 1q23.3 | |
Ifosfamide | Approved | B2M | 567 |
increased | Ifosfamide results in increased expression of B2M protein | 15q21.1 | |
Ifosfamide | Approved | B2M | 567 |
increased | Ifosfamide results in increased expression of B2M protein | 15q21.1 | |
Verapamil | Approved | PRL | 5617 |
increased | Verapamil results in increased expression of PRL protein | 6p22.3 | |